PPH
VanEck Pharmaceutical ETF · Financial Services · Asset Management
Momentum-inputs (vergelijkbare managers):
breedte van houders +25.0% ·
aandelenstroom +2.0% ·
netto nieuwe posities +20.0%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 42 | 0 | 4.70M | $514.35M | +3 | −3 |
| Q1 2026 | 43 | 0 | 4.47M | $464.64M | +6 | −6 |
| Q4 2025 | 43 | -2 | 5.30M | $546.75M | +1 | −3 |
| Q3 2025 | 10 | +2 | 3.22M | $291.27M | +2 | — |
| Q2 2025 | 5 | +1 | 92.39K | $8.13M | +2 | −1 |
| Q1 2025 | 3 | -2 | 1.37M | $124.90M | +1 | −3 |
| Q4 2024 | 5 | 0 | 197.06K | $17.00M | +1 | −1 |
| Q3 2024 | 5 | 0 | 123.94K | $11.78M | +1 | −1 |
| Q2 2024 | 5 | — | 69.03K | $6.31M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Goldman Sachs Group ✦ | 1.90M | — | $171.41M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Morgan Stanley ✦ | 655.59K | — | $59.24M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 655.59K | — | $59.24M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 655.59K | — | $59.24M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 655.59K | — | $59.24M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 655.59K | — | $59.24M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 56.18K | +79.6% | $5.08M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Millennium Management ✦ | 32.90K | Nieuw | $2.97M | 0.0% | New | 1 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 27.85K | -7.9% | $2.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 16.54K | +10.2% | $1.49M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 12.00K | -16.7% | $1.08M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Marshall Wace ✦ | 9.21K | Nieuw | $832,577 | 0.0% | New | 1 | SEC ↗ |
| 21 | Fidelity (FMR) ✦ | 2.20K | +50.5% | $198,714 | 0.0% | ▲ Add | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Millennium Management | $2.97M | 0.0% |
| Marshall Wace | $832,577 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 147 houders, 7.59M aandelen, $716.28M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.